This site is intended for healthcare professionals only
LoginRegister
Expert Drug Panel Clears Proposal to Amend Licensing Forms for Advanced Biologics, XenograftsExpert Drug Panel Clears Proposal to Amend Licensing Forms for Advanced Biologics, Xenografts
Phase 2b trial of RopanicantFirst patient randomized in Ropanicant Phase 2b trial for Major Depressive Disorder: Suven Life...
Sanofi India appoints Haresh Vala as Company Secretary, Compliance OfficerSanofi intravitreal gene therapy wins USFDA fast track designation for geographic atrophy due to...
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP NormsShilpa Medicare Dabaspet unit gets VAI classification from USFDA
Biocon unveils Liraglutide for diabetes, obesity in NetherlandsBiocon Biologics expands biosimilar insulin portfolio with USFDA nod of Kirsty
Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin AmericaBoehringer Ingelheim, LEO Pharma collaborate to commercialize, further develop Spevigo
Centre Extends DCGI Rajeev Singh Raghuvanshis Tenure AgainNo Eligible Successor: Centre Clarifies DCGI's Contractual Reappointment
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDCZydus Gets SEC Nod to Begin Phase IV Trial of Dydrogesterone ER for Habitual Miscarriage
NPPA Finally Allows GSK to Discontinue Grisovin FPCDSCO Panel Approves GSK's Proposal to Double Indian Patient Pool in Dostarlimab Trial
Aurobindo Pharma Gets 5 USFDA Observations for Unit-IV FacilityAurobindo Pharma to manufacture, supply HIV treatment cabotegravir across 133 countries
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusZydus Lifesciences bags USFDA okay for Celecoxib Capsules for juvenile rheumatoid arthritis...
Merck Cuts 150 Jobs at HPV Vaccine Plant as Global Gardasil Sales Fall 39%Merck to begin Phase 3 trials for investigational once monthly HIV prevention pill
X